AAAl-Montaser Bellah H. Ali

Al-Montaser Bellah H. Ali

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Al-Montaser Bellah H. Ali has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Mohamed M. El-Wekil

    Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt

    21 shared publications
  • Mohamed M. El-Wekil

    Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt

    19 shared publications
  • James Barker

    School of Life Sciences, Pharmacy and Chemistry, Kingston University, Kingston upon Thames, London KT1 2EE, UK

    12 shared publications
  • Ashraf M. Mahmoud

    Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Najran University, Najran, Kingdom of Saudi Arabia

    10 shared publications
  • Aya M. Mostafa

    Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt

    10 shared publications
  • Mohamed N. Goda

    Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia

    10 shared publications

Latest Publications

  • Open Access

    A dual-mode γ-CD/Fe,N-CD nanozyme enabled by host–guest interactions for the dual-mode fluorometric and colorimetric monitoring of zearalenone in wheat flour

    by Ashraf M. Mahmoud, Ali O. Alqarni, Rayed Ali A. Alqahtani, Jong Pil Park, Mohamed M. El-Wekil, Ramadan Ali, Al-Montaser Bellah H. Ali

    Zearalenone (ZEN), frequently contaminates cereal-based foods worldwide, necessitating reliable analytical methods for food safety. Image created with the assistance of Google Gemini.

  • Open Access

    Exploiting the intrinsic Michael-acceptor reactivity of osimertinib via thiol-functionalized carbon dots: a mechanistic fluorometric approach

    by Madhawi Alanazi, Khalid Alhazzani, Ahmed Z. Alanazi, Mohamed M. El-Wekil, Imran Mahmood Khan, Al-Montaser Bellah H. Ali

    Osimertinib (OMB) is an EGFR inhibitor used for lung cancer. Its narrow safety margin, PK variability, and degradation in serum make sensitive, selective detection methods essential for therapeutic drug monitoring and pharmacokinetic evaluation.

  • Open Access

    Pharmacophore-targeted fluorescence sensing of ibrutinib via Michael addition-induced electron transfer on thiol-functionalized carbon dots

    by Mohamed N. Goda, Laila S. Alqarni, Faisal K. Algethami, Hossieny Ibrahim, Mohamed M. El-Wekil, Ramadan Ali, Suliman A. Almahmoud, Al-Montaser Bellah H. Ali

    Ibrutinib (IBR), an irreversible inhibitor of Bruton's tyrosine kinase, is commonly used as a first-line therapy for chronic lymphocytic leukemia (CLL) and various other B-cell cancers. Given its narrow therapeutic window and the clinical necessity of long-term administration, accurate therapeutic drug monitoring of IBR in biological fluids is of paramount importance. Herein, we report a novel fluorometric sensing platform for the selective and sensitive determination of IBR based on thiol-functionalized carbon dots (HS-CDs). The sensing mechanism relies on the specific covalent interaction between the –SH groups on HS-CDs and the electrophilic acrylamide moiety of IBR through a rapid Michael addition reaction, which anchors IBR to the CD surface. This binding modifies the local electronic environment of the carbon dots and promotes efficient electron interaction between the electron-rich nitrogen-containing groups of IBR and the CD fluorophore, collectively leading to a concentration-dependent enhancement of fluorescence. The sensor, under optimized conditions, responded linearly from 1.0 to 30.0 ng mL−1, with a minimum detectable concentration of 0.21 ng mL−1. The practical applicability of the platform was demonstrated through the direct quantification of IBR in human serum samples collected from CLL patients, achieving satisfactory recovery values (97.0–100.2%) with minimal sample preparation. The proposed method has strong potential for routine therapeutic drug monitoring in CLL patients undergoing ibrutinib therapy.


  • Iron Sequestration–Modulated Dual‐Readout Sensing of Pyrophosphate and Alkaline Phosphatase via Fenton Oxidation and Fluorescence Recovery

    by Glowi Alasiri, Ali M. Alaseem, Mohamed M. El‐Wekil, Ramadan Ali, Al‐Montaser Bellah H. Ali

    A dual‐mode sensing platform integrating colorimetric and fluorometric detection has been developed for the simultaneous determination of pyrophosphate (PPi) and alkaline phosphatase (ALP) activity. Accurate monitoring of both analytes is clinically significant, as elevated PPi activity and aberrant ALP activity serve as early indicators of disrupted phosphate homeostasis and bone turnover across CKD stages. The platform exploits the Fenton reaction between Fe 2+ and H 2 O 2 to generate Fe 3+ and hydroxyl radicals (•OH); the latter oxidizes TMB to produce a colorimetric signal while Fe 3+ simultaneously quenches carbon dot fluorescence, establishing a coupled dual‐channel baseline. PPi sequesters both Fe 2+ and Fe 3+ , suppressing Fenton chemistry and producing concentration‐dependent attenuation of both signals, while ALP hydrolyzes PPi to release iron ions and restore both channels proportionally to enzyme activity. The colorimetric channel showed a linearity over 1.0–25.0 μM for PPi and over 3.0–18.0 U/L for ALP, while the fluorometric channel demonstrated linear responses across 0.05–7.0 μM for PPi and 0.5–12.0 U/L for ALP, with detection limits of 210 and 14 nM for PPi and 0.91 and 0.15 U/L for ALP in the colorimetric and fluorometric modes, respectively. Validation in spiked serum yielded recoveries of 96.0%–100.9% with RSDs of 1.96%–3.85%, indicating satisfactory accuracy and negligible interference.

  • Open Access

    Ag–Sn@MOFs heterostructure enables ultrasensitive voltammetric determination of vismodegib in serum and urine

    by Glowi Alasiri, Ali M. Alaseem, Razan Orfali, Ramadan Ali, Al-Montaser Bellah H. Ali, Mohamed M. El-Wekil

    Accurate measurement of vismodegib (VIS) is essential for pharmacokinetic profiling, individualized dosing, and therapeutic drug monitoring. In this work, we report an Ag–Sn@MOFs heterostructure as a sustainable composite sensing interface for highly sensitive voltammetric determination of VIS. A simple solvothermal – reduction route yielded an integrated nanocomposite that synergistically combines the high conductivity and electrocatalytic activity of Ag nanoparticles with the high-surface-area, defect-rich architecture of Sn@MOFs. Multimodal characterization verified uniform immobilization of Ag nanoparticles on the Sn@MOFs scaffold and the formation of a stable, conductive interface. Owing to accelerated charge-transfer kinetics and enhanced VIS oxidation, the modified electrode delivered an ultralow limit of detection of 0.006 nM, high sensitivity of 14.782 µA nM−1 cm−2, and a wide linear range of 0.05–500 nM (R2 = 0.9974). Importantly, the sensor maintained excellent accuracy in complex matrices, providing recoveries of 95.6–107.6% with precision ≤3.29% RSD in spiked human urine and serum, demonstrating strong matrix tolerance. The combination of scalable, low-toxicity fabrication with robust selectivity and stability highlights the platform's potential for VIS therapeutic monitoring, pharmacokinetic studies, and translation toward point-of-care diagnostics.


  • Open Access

    A robust dual-readout ratiometric assay for dopamine based on NiMn 2 O 4 -catalyzed DHNP fluorophore conversion

    by Glowi Alasiri, Ali M. Alaseem, Razan Orfali, Ramadan Ali, Al-Montaser Bellah H. Ali, Mohamed M. El-Wekil

    The dual enzyme-mimetic NiMn 2 O 4 nanoflower platform enabled reliable DA detection through a self-calibrated ratiometric fluorescence–colorimetric strategy.


  • Open Access

    A copper-mediated Fenton-like dual-mode optical sensor for sensitive determination of acetylcholinesterase activity in biological fluids

    by Glowi Alasiri, Ali M. Alaseem, Razan Orfali, Mohamed M. El-Wekil, Ramadan Ali, Sally A. El Moumen Zohny, Yasser M. Omar, Al-Montaser Bellah H. Ali

    Acetylcholinesterase (AChE) is a clinically important enzyme, and its accurate and sensitive determination in serum and erythrocytes is of considerable significance for biomedical and toxicological applications. Herein, a novel dual-mode optical sensing platform is reported for the quantitative determination of AChE activity, based on coupling enzymatic thiocholine generation with a copper-mediated Fenton-like redox system. AChE catalyzes the hydrolysis of acetylthiocholine to produce thiocholine, which strongly coordinates Cu(I) and suppresses copper redox cycling. In the absence of AChE, the Cu(I)/H2O2 system proceeds efficiently, generating hydroxyl radicals that oxidize N,N-dimethyl-p-phenylenediamine (DMPD) to a colored product, while concurrently formed Cu(II) quenches the fluorescence of nitrogen- and sulfur-doped carbon dots (N,S-CDs). In the presence of AChE, thiocholine production progressively suppresses radical generation and limits free Cu(II) availability, resulting in decreased absorbance and simultaneous fluorescence recovery. The fluorometric mode exhibited linearity over 0.02–0.6 mU mL−1 with a limit of detection of 0.0068 mU mL−1, while the colorimetric mode showed linearity over a broader range of 0.1–10.0 mU mL−1 with a limit of detection of 0.028 mU mL−1. Applied to spiked serum and erythrocyte samples, the fluorometric and colorimetric modes yielded mean recoveries of 96.50–100.50% and 96.37–102.30%, respectively. The proposed platform offers complementary sensitivity ranges, cross-validated readouts, and practical applicability in complex biological matrices, representing a reliable tool for AChE activity monitoring in clinical and environmental contexts.


  • A novel NIR fluorescent probe based on p -mercaptophenylboronic acid-functionalized copper nanoclusters for capmatinib quantification

    by Ali O. Alqarni, Rayed Ali A. Alqahtani, Ashraf M. Mahmoud, Yahya S. Alqahtani, Bassam S. M. Al Kazman, Fatmah M. Alshareef, Mohamed N. Goda, Laila S. Alqarni, Ramadan Ali, Al-Montaser Bellah H. Ali, et al.

    A red-emitting p -MPBA@CuNC “turn-off” fluorescent probe was developed for highly sensitive and selective capmatinib detection.


  • Enzymatic superoxide generation coupled with dual-signal transduction for gallic acid determination in gallnuts

    by Ali M. Alaseem, Razan Orfali, Glowi Alasiri, Mohamed M. El-Wekil, Ramadan Ali, Al-Montaser Bellah H. Ali

  • Open Access

    Peptide Receptor‐Functionalized AuNP‐Embedded Zwitterionic Biopolymeric Nanohydrogel for Electrochemical Sclerostin Sensing

    by Hyo Jeong Yang, Jae Hwan Shin, Mingi Jo, Changyeon Lee, Hyunmin Yi, Al‐Montaser Bellah H. Ali, Jong Pil Park

    Sclerostin (SOST) is a key negative regulator of bone formation and an emerging biomarker associated not only with osteoporosis but also with chronic kidney disease. Despite its growing clinical relevance, biosensing platforms for SOST remain limited, with most existing approaches relying on antibody‐ or aptamer‐based assays that often suffer from high cost, limited stability, and reduced performance in complex biological samples. Here, we report a peptide‐based electrochemical biosensing platform enabled by a multifunctional zwitterionic biopolymeric nanohydrogel, composed of chitosan, carboxybetaine methacrylate, and gold nanoparticles (CS–ZI–AuNPs). This nanohydrogel acts as a unified antifouling biointerface, simultaneously providing resistance to nonspecific adsorption, stable peptide receptor immobilization, and efficient electrochemical signal transduction. The resulting biosensor achieves picomolar sensitivity with a detection limit of approximately 26.4 pg/mL, enabling accurate quantification of SOST across clinically relevant concentration ranges. Importantly, the platform demonstrates statistically significant discrimination between healthy individuals and patients with osteoporosis, postmenopausal osteoporosis, and chronic kidney disease (stages 1 and 3) using real clinical samples. By integrating zwitterionic antifouling chemistry with peptide‐driven molecular recognition in a conductive nanostructured matrix, this work establishes a generalizable design principle for electrochemical biosensors targeting protein biomarkers. The proposed strategy offers a robust and scalable alternative to conventional immunoassays, with broad implications for translational diagnostics and real‐time disease monitoring.